Lansoprazole

Agopton, Lansobene, Lansoprazol +pharma, Lansoprazol Actavis · ATC code A02BC03

Also known as: Lansoprazol, Prevacid · Brand names: Agopton, Lansobene, Lansoprazol +pharma, Lansoprazol Actavis, Lansoprazol Alternova, Lansoprazol Genericon, Lansoprazol Sandoz, Lansoprazol Stada, Lanso Tad, Lansoprazol Abz, Lansoprazol Al, Lansoprazol Aurobindo, Lansoprazol Ratiopharm, Aprazol, Degastrol …

Key facts
Active substance
Lansoprazole
ATC code
A02BC03
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-10-29

Key facts

Lansoprazole is a proton pump inhibitor. Per the US prescribing information (PREVACID), it is used for gastric and duodenal ulcers, reflux disease and H. pylori eradication.

What it is used for

  • Active duodenal ulcer and maintenance of healed ulcers; H. pylori eradication (triple or dual therapy) to reduce recurrence
  • Benign gastric ulcer; healing and risk reduction of NSAID-associated gastric ulcer
  • Gastroesophageal reflux disease and erosive esophagitis, including maintenance
  • Pathological hypersecretory conditions including Zollinger-Ellison syndrome

Dosing

  • Duodenal ulcer: 15 mg once daily for 4 weeks; H. pylori: 30 mg twice daily with amoxicillin and clarithromycin for 10 or 14 days, or 30 mg three times daily with amoxicillin for 14 days
  • Symptomatic GERD: 15 mg once daily for up to 8 weeks; erosive esophagitis: 30 mg once daily for up to 8 weeks, maintenance 15 mg once daily
  • Zollinger-Ellison syndrome: start 60 mg once daily, adjust individually
  • Children 1 to 11 years: 15 mg (30 kg or less) or 30 mg (over 30 kg) once daily for up to 12 weeks
  • Severe hepatic impairment (Child-Pugh C): 15 mg daily; take before meals

Contraindications

  • Known hypersensitivity to any component
  • Concomitant rilpivirine-containing products

Important warnings

  • Symptomatic response does not preclude gastric malignancy
  • Acute tubulointerstitial nephritis; discontinue if suspected
  • Clostridium difficile-associated diarrhea; use the lowest dose and shortest duration
  • Bone fractures with high-dose, long-term therapy; severe cutaneous reactions, lupus erythematosus
  • Vitamin B12 deficiency, hypomagnesemia, fundic gland polyps

Side effects

  • Generally well tolerated
  • Diarrhea 3.8%, abdominal pain 2.1%, nausea 1.3%, constipation 1.0%

Interactions

  • Rilpivirine contraindicated; interactions with certain antiretrovirals, warfarin, methotrexate, digoxin, theophylline and tacrolimus (see the full text)
  • CYP2C19 or CYP3A4 inducers and inhibitors alter lansoprazole levels
  • Sucralfate: take lansoprazole at least 30 minutes before
  • May affect neuroendocrine tumor investigations and the secretin stimulation test; false positive urine THC tests

Pregnancy and breastfeeding

  • Observational studies overall do not indicate an association with adverse pregnancy outcomes
  • No information on presence in human milk

Summary of the official product information, written with AI on 2026-10-29. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

This product has no separate US patient information.

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Austria

  • AgoptonTakeda Pharma Ges.M.B.H. · 1 register entry
  • LansobeneTeva B.V · 1 register entry
  • Lansoprazol +pharma+pharma Arzneimittel Gmbh · 1 register entry
  • Lansoprazol ActavisActavis Group Ptc Ehf. · 2 register entries
  • Lansoprazol AlternovaKrka, D.D., Novo Mesto · 1 register entry
  • Lansoprazol GenericonGenericon Pharma Gesellschaft M.B.H. · 1 register entry
  • Lansoprazol SandozSandoz Gmbh · 1 register entry
  • Lansoprazol StadaStada Arzneimittel Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29

Germany

  • Lanso TadTad Pharma Gmbh · 1 register entry
  • Lansoprazol AbzAbz-Pharma Gmbh · 1 register entry
  • Lansoprazol AlAliud Pharma Gmbh · 1 register entry
  • Lansoprazol AurobindoPuren Pharma Gmbh & Co. Kg · 1 register entry
  • Lansoprazol RatiopharmRatiopharm Gmbh · 1 register entry
  • Lansoprazol StadaStadapharm Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29

Turkey

  • AprazolHÜSNÜ ARSAN İLAÇLARI A.Ş. · 2 register entries
  • DegastrolDEVA HOLDİNG A.Ş. · 4 register entries
  • ElingerNEUTEC İLAÇ SAN. TİC. A.Ş · 3 register entries
  • LansazolSANDOZ İLAÇ SAN. VE TİC. A.Ş. · 4 register entries
  • LansoprolNOBEL İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
  • LansorSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
  • LansoterTERRA İLAÇ VE KİMYA SAN. TİC. A.Ş. · 2 register entries
  • LanzapİSTANBUL İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
  • LanzedinBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
  • LapiloriDROGSAN İLAÇLARI SAN. VE TİC. A.Ş. · 3 register entries
  • LasotabNUVOMED İLAÇ SAN.TİC. A.Ş. · 3 register entries
  • LukazrolUMUT İLAÇ TİC. VE SAN. LTD. ŞTİ. · 2 register entries
Show all 17 brand names
  • OpagisLİLYUM İLAÇ VE KİMYA SAN. TİC. A.Ş. · 2 register entries
  • PepticerİLKO İLAÇ SAN.VE TİC. A.Ş. · 3 register entries
  • PeptizolBERKO İLAÇ VE KİMYA SAN. A.Ş. · 2 register entries
  • VogastFARMALAS İLAÇ SAN. VE TİC. LTD. ŞTİ. · 2 register entries
  • ZoprolTOPRAK İLAÇ VE KİMYEVİ MADDELER SAN.VE TİC. A.Ş. · 2 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

USA

  • PrevacidTakeda Pharmaceuticals America, Inc. · 1 register entry
  • Prevacid SoluTabTakeda Pharmaceuticals America, Inc. · 1 register entry

Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-29

Brand names in 27 more European countries
Belgium
Lansoprazol Ab, Lansoprazol Krka, Lansoprazol Sandoz, Lansoprazole Eg, Lansoprazole Teva
Bulgaria
Ланзацид, Ланзопразол Екофарм, Ланзул, Лансопрол
Croatia
Lanzul
Cyprus
Lanso
Czechia
Lanxib, Lanzul
Denmark
Lansoprazol "doc", Lansoprazol "viatris", Lansoprazol Krka, Lansoprazol Medical Valley, Lansoprazol Stada, Lansoprazole Teva, Zolt
Estonia
Lanzostad, Lanzul
Finland
Gasterix, Lansoprazol Krka, Lanvone, Zolt
France
Lansoprazole Almus Pharma, Lansoprazole Arrow, Lansoprazole Bgr, Lansoprazole Biogaran, Lansoprazole Cristers, Lansoprazole Eg, Lansoprazole Evolugen, Lansoprazole Krka, Lansoprazole Sandoz, Lansoprazole Sun, Lansoprazole Teva Sante, Lansoprazole Viatris, Lansoprazole Zentiva, Lansoprazole Zydus, Lanzor, Ogast, Ogastoro
Greece
Lanciprol, Lanso, Lanzol, Laprazol, Zoletad
Hungary
Emillan, Lansoprazol Teva, Lansoprazole Teva, Lansoptol, Protonexa, Refluxon
Iceland
Lansoprazol Krka
Ireland
Lansoprazole Accord, Lansoprazole Krka, Lansoprazole Pinewood Laboratories, Lansoprazole Teva Pharma, Lanzol, Razolager, Zomel, Zoton Fastab
Italy
Ermes, Frilans, Krovaneg, Lansocel, Lansodor, Lansoprazolo Abc, Lansoprazolo Almus, Lansoprazolo Alter, Lansoprazolo Aurobindo, Lansoprazolo Doc, Lansoprazolo Eg, Lansoprazolo Fg, Lansoprazolo Hexal, Lansoprazolo Krka, Lansoprazolo Laboratori Alter, Lansoprazolo Mylan Generics, Lansoprazolo Pensa, Lansoprazolo Sandoz Bv, Lansoprazolo Sun, Lansoprazolo Tecnigen, Lansoprazolo Tecnimede, Lansoprazolo Teva Italia, Lansoprazolo Zentiva, Lansox, Levogenix, Limpidex, Peptirex, Pergastid, Tanzolan, Zoton
Latvia
Lanzostad, Lanzul
Lithuania
Lanobax, Lanzostad, Lanzul
Luxembourg
Lansoprazol Ratiopharm, Lansoprazole Eg
Malta
Lanzol
Netherlands
Lansoprazol Viatris, Lansoprazole Aurobindo
Norway
Lansoprazol Krka, Lansoprazol Medical Valley, Lanzo Melt
Poland
Lanzul, Renazol, Zalanzo
Portugal
Alexin, Belmural, Dispepci, Gastroliber, Lansoprazol Alexin, Lansoprazol Alter, Lansoprazol Aurovitas, Lansoprazol Azevedos, Lansoprazol Baldacci, Lansoprazol Basi, Lansoprazol Biofarmoz, Lansoprazol Blixie, Lansoprazol Bluepharma, Lansoprazol Ciclum, Lansoprazol Farmoz, Lansoprazol Gastroliber Pentafarma, Lansoprazol Generis, Lansoprazol Krka, Lansoprazol Lanzogastro, Lansoprazol Mylan, Lansoprazol Omnicals, Lansoprazol Pentafarma Especialidades, Lansoprazol Pharmakern, Lansoprazol Quimedical, Lansoprazol Ratiopharm, Lansoprazol Sandoz, Lansoprazol Tecnigen, Lansoprazol Tetrafarma, Lansoprazol Teva, Lansoprazol Tolife, Lansoprazol Viatris, Lansoprazol Zentiva, Lapol, Monolitum, Ogasto, Ulcertec
Romania
Lanzul, Levant
Slovakia
Lanzul
Slovenia
Lanzul
Spain
Duomate Flas, Estomil, Lansoprazol, Lanzol, Monolitum, Opiren, Pro-Ulco, Procesol
Sweden
Lansoprazol Krka, Lansoprazol Medical Valley, Lansoprazol Ranbaxy, Lansoprazol Teva, Lansoprazol Viatris, Lanzo

EMA – Article 57 product data (EU/EEA), 2026-10-29

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Prevacid (Takeda Pharmaceuticals America, Inc.) – Prescribing Information, 2025-07-08. DailyMed (NLM), 2026-10-29. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71ba78cb-7e46-43eb-9425-fa130f537f84
  2. EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  5. U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-29. https://dailymed.nlm.nih.gov/dailymed/

Editorial: Medelix editorial team · last updated 2026-10-29 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.